Success FCE Pharma 2021! Date Wednesday, December 29, 2021 / SynZeal exhibited at FCE Pharma 2021 at Sau Paulo, Brazil. Our sales and technical team had the opportunity to meet all current and prospective customers. Congratulations to the SynZeal team for making this FCE Pharma 2021 a grand success. We could feel the energy of the people who visited us during this difficult time. Read More
Dapagliflozin Date Wednesday, December 29, 2021 / Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor indicated for managing diabetes mellitus type 2. When combined with diet and exercise in adults, dapagliflozin helps to improve glycemic control by inhibiting glucose resorption in the proximal tubule of the nephron and causing glycosuria. Dapagliflozin was approved by the FDA on 2014. SynZeal offers all Dapagliflozin related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Dapagliflozin related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing. Read More
Daclatasvir Date Wednesday, September 22, 2021 / Daclatasvir is an orally available inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex, with potential activity against HCV. Daclatasvir use with Sofosbuvir with or without Ribavirin to treat HCV genotype 1 and 3 infections. Daclatasvir was FDA-approved in July 2015. Read More
SynZeal is exhibiting in FCE Pharma 2021 in Sao Paulo, Brazil ! Date Friday, September 17, 2021 / FCE pharma is highly acclaimed and much anticipanted event for pharmaceutical industry in Latin America. SynZeal will be presenting at FCE Pharma 21 at Booth No G-083 during this event scheduled on Nov 30- Dec 02, 2021 at Sao Paulo Expo, Brazil. Read More
Dabigatran Date Wednesday, September 8, 2021 / Dabigatran is a direct inhibitor of thrombin and anticoagulant which is used for prevention of stroke and venous embolism in patients with chronic atrial fibrillation. Dabigatran was approved for medical use in 2010. Read More
Cyanocobalamin Date Thursday, August 19, 2021 / Cyanocobalamin is a highly complex, essential vitamin, owing its name to the fact that it contains the mineral, cobalt. This vitamin is produced naturally by bacteria, and is necessary for DNA synthesis and cellular energy production. In the cobalamins, cobalt normally exists in the trivalent state, Co(III). However, under reducing conditions, the cobalt centre is reduced to Co(II) or even Co(I), which are usually denoted as B12r and B12s, for reduced and super reduced, respectively. Read More
Dabigatran Date Sunday, August 8, 2021 / Dabigatran is a direct inhibitor of thrombin and anticoagulant which is used for prevention of stroke and venous embolism in patients with chronic atrial fibrillation. Dabigatran was approved for medical use in 2010. Read More
Colchicine Date Monday, July 12, 2021 / Colchicine is an alkaloid isolated from Colchicum autumnale with anti-gout and anti-inflammatory activities. colchicine is an alkaloid drug commonly used in the management of gout; a condition associated with the painful deposition of urate crystals in the joints. Read More
Colesevelam Date Tuesday, July 6, 2021 / Colesevelam Hydrochloride is a hydrochloride salt form of colesevelam, a non-absorbed polymer that binds bile acids in the intestine and lowers serum lipids. Colesevelam is used with exercise and diet changes to reduce the amount of cholesterol and certain fatty substances in the blood. Read More
Clobetasol propionate Date Monday, June 28, 2021 / Clobetasol propionate is a prednisolone derivative with higher specificity for glucocorticoid receptors than mineralocorticoid receptors. It is used to treat various skin disorders, including eczema and psoriasis. It has a role as an anti-inflammatory drug. Read More